Evidence map›Paper›PMID 38854821›Full record

ArticleResearch and practice in thrombosis and haemostasis2024

Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress.

Chris Ward, Nicola Curry, Magdy El-Ekiaby, Kerstin Jurk, Henri H Versteeg, Charithani Keragala, Tal Burstyn-Cohen, Silvio Antoniak, Yuko Suzuki, Ross I Baker and 21 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Transfusion biomaterials for hemostasis.Journal of thrombosis and haemostasis : JTH · 2025
    Review
  2. Transfusion in trauma: empiric or guided therapy?Research and practice in thrombosis and haemostasis · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

Chris WardSydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Nicola CurryOxford University and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Magdy El-EkiabyShabrawishi Hospital Hematology Unit, Cairo, Egypt.
Kerstin JurkCenter for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Henri H VersteegLeiden University Medical Center, Leiden, the Netherlands.
Charithani KeragalaAustralian Centre for Blood Diseases, the Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Tal Burstyn-CohenInstitute for Biomedical and Oral Research (IBoR), The Hebrew University of Jerusalem, Jerusalem, Israel.
Silvio AntoniakUNC Blood Research Center, Department of Pathology and Laboratory Medicine, UNC Lineberger Comprehensive Cancer Center, UNC McAllister Heart Institute, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Yuko SuzukiMedical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Ross I BakerPerth Blood Institute, Murdoch University, Perth, Western Australia, Australia.
Olivier ChristopheUniversité Paris-Saclay, INSERM, Hémostase Inflammation Thrombose (HITh U1176), Le Kremlin-Bicêtre, France.
Shoshana Revel-VilkPediatric Hematology/Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
Alice HartImperial College London, Imperial College Healthcare NHS Trust, London, United Kingdom.
Carsten DeppermannCenter for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany.
Huyen TranThe Alfred Hospital, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
Nicola PozziSaint Louis University, St. Louis, Missouri, USA.
Walter H A KahrHospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Steven P GroverUNC Blood Research Center, Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Philip WenzelUniversity Medical Center Mainz, Mainz, Germany.
Ashley C BrownJoint Department of Biomedical Engineering at North Carolina State University and the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Cécile OuryGIGA Research Institute, University of Liège, Liège, Belgium.
Susan M SheaTrauma and Transfusion Medicine Research Center, Department of Surgery and Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
James FredenburghMcMaster University, Hamilton, Ontario, Canada.
Freda H PassamUniversity of Sydney, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
James WinearlsGold Coast University Hospital, St Andrews War Memorial Hospital, Monash University, University of Queensland, Brisbane, Queensland, Australia.
Hunter B MooreAdventHealth Transplant Institution at Porter, Denver, Colorado, USA.
Soumitra ToleChildren's Hospital, London Health Sciences Center, Western University, London, United Kingdom.
Eileen MerrimanNorth Shore Hospital, Auckland, New Zealand.
Geoffrey D BarnesFrankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, USA.
Z Leonardo LiuFlorida State University, Tallahassee, Florida, USA.
Michelle SholzbergSt Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada.

Funding

Medical Research Council MR/T023961/1
6 · The paper itself

Abstract

Here, we present a series of illustrated capsules from the State of the Art (SOA) speakers at the 2024 International Society on Thrombosis and Haemostasis Congress in Bangkok, Thailand. This year's Congress marks the first time that the International Society on Thrombosis and Haemostasis has held its flagship scientific meeting in Southeast Asia and is the first to be organized by an international Planning Committee. The Bangkok program will feature innovative science and clinical updates from around the world, reflecting the diversity and multidisciplinary growth of our field. In these illustrated SOA capsules, you will find an exploration of novel models of thrombosis and bleeding and biomaterial discoveries that can trigger or block coagulation. Thromboinflammation is now understood to drive many disease states, and the SOA speakers cover cellular and coagulation responses to COVID-19 and other infections. The theme of crosstalk between coagulation and inflammation expands with capsules on protein S signaling, complement, and fibrinolytic inhibitors. Novel agents for hemophilia and thrombosis prevention are introduced. Challenging clinical conditions are also covered, such as inherited platelet disorders and antiphospholipid antibody syndrome. The scientific program in Bangkok will also showcase the work of clinicians and scientists from all parts of the world and chronicle real-world challenges. For example, 2 SOA capsules address the diagnosis and management of von Willebrand disease in low-income settings. Take some time to browse through these short illustrated reviews; we're sure that you'll be entertained, educated, and inspired to further explore the world of thrombosis and hemostasis.

Identifiers

PMID38854821
PMCPMC11157278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.